SXI Life Sciences
7.675,65
PKT
-28,96
PKT
-0,38
%
Werbung
Analysen zu SXI Life Sciences-Werten
Datum | Rating | Analyst | |
---|---|---|---|
07.01.10 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) | |
07.01.10 | Novartis halten | Credit Suisse Group | |
05.01.10 | Novartis kaufen | Citigroup Corp. | |
05.01.10 | Novartis halten | Société Générale Group S.A. (SG) | |
06.01.10 | Novartis kaufen | UBS AG | |
04.01.10 | Novartis halten | Independent Research GmbH | |
04.01.10 | Novartis halten | SEB AG | |
23.12.09 | Novartis buy | Helvea | |
10.12.09 | Novartis hold | Société Générale Group S.A. (SG) | |
11.12.09 | Novartis buy | Citigroup Corp. | |
09.12.09 | BB Biotech kaufen | Hamburger Sparkasse AG (Haspa) | |
09.12.09 | Novartis akkumulieren | Independent Research GmbH | |
09.12.09 | Novartis buy | Helvea | |
11.12.09 | Novartis buy | Goldman Sachs Group Inc. | |
08.12.09 | Novartis buy | Citigroup Corp. | |
03.12.09 | Novartis buy | Société Générale Group S.A. (SG) | |
03.12.09 | Novartis buy | UBS AG | |
30.11.09 | Novartis buy | Helvea | |
26.11.09 | Novartis underperform | Cheuvreux SA | |
25.11.09 | Novartis outperform | Exane-BNP Paribas SA | |
24.11.09 | Novartis buy | Goldman Sachs Group Inc. | |
24.11.09 | BB Biotech | Wirtschaftswoche | |
24.11.09 | Novartis overweight | JP Morgan Chase & Co. | |
17.11.09 | Novartis akkumulieren | Independent Research GmbH | |
17.11.09 | Novartis | Wirtschaftswoche | |
16.11.09 | Novartis equal-weight | Morgan Stanley | |
13.11.09 | Novartis underweight | Barclays Capital | |
13.11.09 | Novartis | Focus Money | |
10.11.09 | Novartis overweight | JP Morgan Chase & Co. | |
09.11.09 | Lonza kaufen | Die Actien-Börse | |
06.11.09 | Novartis | Der Aktionärsbrief | |
09.11.09 | Novartis buy | UBS AG | |
12.11.09 | Novartis kaufen | Raiffeisen Centrobank AG | |
22.10.09 | Novartis buy | Société Générale Group S.A. (SG) | |
22.10.09 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) | |
22.10.09 | Novartis akkumulieren | Independent Research GmbH | |
22.10.09 | Novartis outperform | Cazenove Group Limited | |
21.10.09 | Novartis equal-weight | Morgan Stanley | |
14.10.09 | Novartis buy | Helvea | |
12.10.09 | Novartis outperform | Cowen and Company, LLC |